Company/Division name | Biotrial S.A. |
Parent company | Biotrial S.A. |
Type of work | IT |
Reshoring category: | Transplant |
Total number of jobs (added or to be added): | 60 |
Year reshoring announced: | 2013 |
Year reshoring implemented or to be implemented: | 2014 |
Domestically, the work will be done: | In-house |
Country(ies) from which reshored: | France |
City reshored to: | Newark |
State(s) reshored to: | NJ |
If relevant, work nearshored to: | - |
Industry(ies): | Other, Research/Services |
Product(s) reshored | pharmaceutical testing |
What non-domestic negative factors made offshoring less attractive? | Regulatory compliance |
What domestic positive factors made reshoring more attractive? | Eco-system synergies, Infrastructure, Skilled workforce availability/training |